Title : Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.

Pub. Date : 2021 May 18

PMID : 32667979






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a Phase 1 dolutegravir-efavirenz interaction study, mean dolutegravir Cmin decreased by 60% and 85% among CYP2B6 normal and slow/intermediate metabolizers, respectively. dolutegravir cytochrome P450 family 2 subfamily B member 6 Homo sapiens